+203.1%
MRNA vs RPRX
+78.9%
+124.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | RPRX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.1% | -3.3% | -2.8% |
| 7D | -12.7% | -1.2% | -11.5% | -12.1% |
| 30D | -20.7% | +10.5% | -31.2% | -25.3% |
| 3M | +46.3% | +13.4% | +32.9% | +35.9% |
| 6M | +305.2% | +30.0% | +275.3% | +259.6% |
| YTD | +561.2% | +80.2% | +481.0% | +412.9% |
| 1Y | +772.1% | +81.4% | +690.7% | +574.9% |
| 3Y | +147.0% | +173.3% | -26.3% | +60.9% |
| 5Y | -26.1% | +85.0% | -111.1% | -44.2% |
| All | +203.1% | +78.9% | +124.1% | +117.6% |
Cumulative growth
Daily Returns
Daily percentage return beside RPRX.
Daily Out/Under-Performance
Portfolio return minus RPRX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RPRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded RPRX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling